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Victoria Manning (London), Gemma Cox, Niamh Ryder (Dublin),
Jozsef Gerevich, Erika Bácskai (Budapest), Miguel Casas, 
Josep Lluis Matali (Barcelona), Michael Krausz (Hamburg) 
(1) youth, especially in the party scene; (2) socially mar-
ginalized groups, such as homeless and prostitutes or 
those found in open drug scenes; (3) opiate-dependent 
patients in maintenance treatment who additionally use 
cocaine. Specifi c strategies need to be developed to ad-
dress problematic cocaine use in these subgroups. 
 Copyright © 2004 S. Karger AG, Basel 
 Introduction 
 There has been an extensive ﬁ eld of research on co-
caine use and dependence, which ranges from basic re-
search to clinical and social research. There is sufﬁ cient 
evidence that cocaine use can be found in all social class-
es of society, that the social context has a signiﬁ cant effect 
on the patterns of use as well as on the risk of dependence. 
Cocaine dependence, although not affecting all cocaine 
users, is a serious threat for the mental and physical health 
of cocaine users. The treatment options remain limited, 
but research has shown some promising forms of inter-
ventions. 
 Key Words 
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 Abstract 
 An increase in the use of cocaine and crack in several 
parts of Europe has raised the question whether this 
trend is similar to that of the USA in the 1980s. However, 
research in the fi eld of cocaine use in Europe has been 
only sporadic. Therefore, a European multi-centre and 
multi-modal project was designed to study specifi c as-
pects of cocaine and crack use in Europe, in order to de-
velop guidelines for public health strategies. Data on 
prevalence rates were analysed for the general popula-
tion and for specifi c subgroups. Despite large differ ences 
between countries in the prevalence of cocaine use in 
the general population, most countries show an increase 
in the last few years. The highest rate with a lifetime 
prevalence of 5.2% was found for the United Kingdom, 
although with a plateau effect around the year 2000. With 
regard to specifi c subgroups, three groups seem to 
show a higher prevalence than the general population: 
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 Cocaine and crack use always has to be considered in 
light of the social context, so that generally the assessment 
differs for each individual country. Nonetheless, some 
aspects may be of importance for the European situation 
when looking at cocaine use in the USA. From 1972 to 
1982 the lifetime prevalence of cocaine use in the gen-
eral US population increased from 1.6 to 8.5% for older 
adults and 9.1 to 28.3% among younger adults. After 
reaching a peak in 1985, a decline occurred in lifetime 
use, though not however in cocaine dependence  [1] . Crack 
developed in the 1980s largely in response to the absence 
of high-quality, inexpensive cocaine. It ﬁ rst appeared as 
a problem in 1986 in New York, Los Angeles and Miami 
and then quickly spread to other cities. 
 It remains unclear how many cocaine and crack users 
are able to use without serious problems or how many 
become dependent. Cocaine dependence disorder shows 
different clinical characteristics in relation to dose, ad-
ministration route, and length and pattern of use. In gen-
eral, drug abuse liability and intoxication intensity are 
directly related to the bioavailability of the substance in 
the central nervous system, and positively correlated with 
the subjective sensation of euphoria. Furthermore, the 
duration of the euphoric effects is inversely related to the 
speed of the initiation of the drug’s activity  [2] . Therefore, 
administration route is an important factor in the evolu-
tion of cocaine dependence. Abuse or dependence can 
take years to develop when cocaine is sniffed, while smok-
ing and injecting the drug can lead to dependence or 
abuse within months or even weeks  [3] . The effects of 
cocaine once a person is dependent are different from 
those experienced during occasional use. The dependent 
person often experiences mood swings, anxiety, irritabil-
ity, aggression and paranoid ideation, lack of interest in 
anything not related to the acquisition and consumption 
of the drug, social isolation, and progressive personal and 
social deterioration. Decompensation of pre-existing psy-
chiatric disorders, such as schizophrenia, is frequent, and 
there is an increase in frequency and intensity of symp-
toms in patients with anxiety disorders and depressive 
states  [2] . Another important aspect is the fact that co-
caine use is seldom isolated – the comorbidity with the 
use of other substances is quite high (i.e. 84% comorbid-
ity with alcohol dependence  [1] ). 
 Until now, none of the diverse psychopharmacologic 
treatments tested have demonstrated assured efﬁ cacy. It 
is notable that distinct pharmacological therapies have 
been developed on the basis of the modiﬁ cation of cere-
bral dopaminergic transmission. In general, two principal 
strategies have been studied. Dopamine receptor antago-
nist agents have been used to counteract cocaine’s gratify-
ing effects, and, in an opposite manner, agents that fa-
cilitate dopaminergic transmission have been used to 
counteract the dopamine deﬁ cit observed during with-
drawal  [4, 5] . 
 As the results for pharmacological treatment options 
have not been successful so far, this has increased the im-
portance of psychosocial interventions to modify the ad-
dictive behaviour of cocaine dependent persons. The only 
large-scale randomised clinical trial in the ﬁ eld of addic-
tion, where the effects of a psychosocial intervention have 
been systematically tested, can be found in the ﬁ eld of 
cocaine dependence: A large trial studied the efﬁ cacy of 
four different psychosocial interventions for cocaine de-
pendent patients  [6] . The four interventions were: cogni-
tive psychotherapy, psychodynamic psychotherapy, indi-
vidual counselling and group counselling. All psychosocial 
interventions showed a signiﬁ cant efﬁ cacy in the reduc-
tion of cocaine use. The two psychotherapies were more 
effective in retention, the two counselling methods were 
more effective in abstinence rates. 
 The social situation of cocaine and crack users in the 
USA is best summarized in the work by Reinarman and 
Levine  [7] : All social classes are known to use cocaine, 
while it is mainly the middle and upper classes that use 
cocaine powder and the lower class that uses crack. De-
pending on the social class, in which the substance is used, 
a clear relationship can be found with other social con-
textual factors, such as violence, homelessness and unem-
ployment. In the US, crack has also become the cocaine 
form mainly used by African-American and Latino mi-
norities, while cocaine powder is used mainly by the Cau-
casian majority. However, this relationship is obviously 
tied to the economic status. 
 There is sufﬁ cient evidence showing that social con-
textual factors play an important role in the extent of 
problems related to cocaine use. Therefore, evidence on 
effects of cocaine use from the USA cannot simply be ex-
trapolated to Europe on a one-to-one basis. The lack of 
research on cocaine use in Europe lead to the design of 
this multi-centre study, with the aim of collecting data 
that will help us understand European aspects of cocaine 
use. 
 Methods 
 The research project ‘Support needs for cocaine and crack users 
in Europe (cocinEU)’ was initiated in January 2002 and completed 
in December 2003. This multi-centre, multi-modal research project 
was aimed at deﬁ ning target group speciﬁ c recommendations 
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(‘guidelines’) in order to ameliorate the speciﬁ c care for regular co-
caine and crack users. The recommendations are to include infor-
mation about how addiction services in the major European capi-
tals can meet the challenge of rising cocaine and crack consumption. 
The project was initially carried out by research centres in nine 
European cities (Barcelona, Budapest, Dublin, Hamburg, London, 
Rome, Stockholm, Vienna, Zurich), while a tenth research centre 
(Paris) joined in during the course of the project. 
 The investigation includes research from three different per-
spectives: (1) the user perspective; (2) the policy-maker perspective; 
(3) the research perspective. A multimodal approach was chosen 
( table 1 ). 
 The prevalence estimates were designed to provide a measure 
of cocaine use, especially the prevalence of problematic cocaine use. 
The most comprehensive and comparable data on substance use in 
different European countries is provided by the European Monitor-
ing Centre for Drugs and Drug Addiction (EMCDDA, www.emcd-
da.eu.int): The EMCDDA has established a set of ﬁ ve key indica-
tors for this work. These are: prevalence and patterns of drug use 
among the general population (population surveys); prevalence and 
patterns of problem drug use (statistical prevalence/incidence esti-
mates and surveys among drug users); drug-related infectious dis-
eases (prevalence and incidence rates of HIV, hepatitis B and C in 
injecting drug users); drug-related deaths and mortality of drug us-
ers (general population mortality special registers statistics, and 
mortality cohort studies among drug users); demand for drug treat-
ment (statistics from drug treatment centres on clients starting 
treatment). Furthermore, the EMCDDA work also targets drug 
trends in youth, drug-related crime, drug-related social exclusion 
and availability of illicit drugs. 
 Nonetheless, EMCDDA statistics do not necessary reﬂ ect the 
local realities of cocaine use in cities, where other data can be in-
cluded in order to arrive at a more comprehensive picture of co-
caine use. These vary from one centre to the next, including treat-
ment data, mortality data and police data. Other centres utilised 
studies on special subgroups, such as homeless or socially marginal-
ized people, pupils and students, recruited soldiers or cocaine users 
in recreational contexts. 
 Results on Prevalence Estimates 
 The results on prevalence estimates can be divided 
into two categories: 
 Lifetime and 12-month prevalence in the general pop-
ulation. 
 Prevalence in special subgroups. 
 Lifetime and 12-Month Prevalence 
 Figures on lifetime and 12-month prevalence are in 
most part national ﬁ gures, derived by epidemiological 
studies mainly through the focal points of the EMCDDA 
in the respective country ( table 2 ). Speciﬁ c city preva-
lence rates were not available in most centres except for 
Stockholm: About 3% each year of the 5,500 registered 
drug addicts from 1988 to 1991 in the Stockholm area 
had used cocaine and a few persons had used crack  [8] . 
 Prevalence in Special Subgroups 
 Published data on special subgroups using cocaine can 
be found according to three criteria: age, treatment status 
and social subgroups. With respect to age, there are sev-
eral reports on cocaine use among youth samples. Differ-
ent treatment samples are evaluated with respect to co-
caine use. And several descriptive studies evaluate cocaine 
use among social subgroups such as prisoners, homeless, 
prostitutes, and other groups. Since these vary from one 
country to the next, the results are presented by country. 
As not all centres delivered information on prevalence 
among subgroups, only those with a report are presented. 
Table 1. Components of the multimodal methodology
1 Literature analysis and prevalence estimates: In each location 
the national literature on cocaine and crack was analysed, in-
cluding unpublished reports and ‘grey’ literature. A special fo-
cus was placed on epidemiological data, in order to come up 
with an estimate of cocaine use, especially the prevalence of 
problematic cocaine use.
2 Standardized user interviews: Problematic cocaine and crack 
users from three target subgroups were interviewed as to their 
social and health status as well as their need for support [for 
inclusion criteria as well as instruments used, see Prinzleve et 
al., this issue].
3 Qualitative user interviews: These interviews will be carried out 
in order to gain detailed information about consumers, espe-
cially about their problems within the addiction treatment.
4 Analysis of drug emergencies: Documentation of the drug emer-
gency facilities in the different study locations will be analysed 
as to the impact of cocaine and crack consumers and what kind 
of somatic and psychological complications occurred.
5 Expert interviews: A systematic analysis of existing support of-
fers for target groups will be executed in the respective study 
locations. A base-line of local problems as well as public health 
and social political strategies in dealing with cocaine and crack 
consumers.
6 Development of possible public health strategies: Due to this 
integration of different dimensions of the study the empirically 
founded need for support can be deﬁ ned and recommendations 
can be elaborated. On local town conferences the results and 
ﬁ ndings of the study will be discussed in detail with representa-
tives and people in charge from the cooperating study loca-
tions.
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Country* Lifetime prevalence 12-month prevalence
Germany** 1990: 18–39 years: 1.5%
1995: 18–39 years: 3.7%
2000: 18–39 years: 3.8%
2000: 18–59 years: 2.4%, crack 0.1% [12]
15–64 years:
1995: 1.9%
1997: 1.4%
2000: 2.3%
18–39 years:
2000: 3.6%
15–34 years:
1990: 1.3%
1995: 3.6%
1997: 2.2%
2000: 4.0% [46]
1990: 18–39 years: 0.4%
1995: 18–39 years: 1.6%
2000: 18–59 years: 0.9% [12]
15–64 years:
1995: 0.8%
1997: 0.6%
2000: 0.9%
18–39 years:
2000: 1.5%
15–34 years:
1990: 0.4%
1995: 1.8%
1997: 1.3%
2000: 1.9% [46]
United Kingdom 15–64 years:
1994: 2.4%
1996: 3.1%
1998: 3.8%
2000: 5.6%
2001/2: 5.2%
15–34 years:
1994: 3.4%
1996: 4.4%
1998: 5.8%
2000: 9.8%
2001/2: 8.7% [46]
15–64 years:
1994: 0.5%
1996: 0.6%
1998: 1.3%
2000: 2.0%
2001/2: 2.0%
15–34 years:
1994: 0.9%
1996: 1.3%
1998: 2.4%
2000: 4.5%
2001/2: 4.0% [46]
16–59 years:
1994: 0.5%
2000: 2% [26]
Switzerland 1992/3: 15–39 years: 2.7%, crack 0.1%
1997/8: 15–39 years: 3.3% [47, 48]
1992/3: 15–39 years: 0.44%
1997/8: 15–39 years: 0.37% [48]
Sweden 1988–2000: 15–75 years: 1–2% [49]
15–64 years:
1994: <0.5%
1996: 1.0%
1998: 1.0%
2000: 1.0% [46]
15–64 years:
1998: <0.5%
2000: 0.0% [46]
Italy 2001: 15–64 years: 1.1%
2001: 15–34 years: 1.8%
Ireland 1998: 15–64 years: 1.3%
1998: 15–34 years: 2.6% [46]
Spain 15–65 years:
1995: 3.4%
1997: 3.2%
1999: 3.1% [45]
15–64years:
1995: 3.7%
1997: 3.3%
1999: 3.2%
2001: 4.9%
15–34 years:
1995: 5.9%
1997: 5.2%
1999: 4.8%
2001: 7.7% [46]
15–65 years:
1999: 1.5% [45]
15–64 years:
1995: 1.9%
1997: 1.6%
1999: 1.6%
2001: 2.6%
15–34 years:
1995: 3.4%
1997: 2.8%
1999: 2.7%
2001: 4.6% [46]
* No data available for Austria and Hungary.
** Data only for West Germany, cocaine use in East Germany much lower.
Table 2. Lifetime and 12-month prevalence 
rates of cocaine use*
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 Germany 
 Three groups of cocaine users seem to be relevant in 
Germany  [9] : party goers (mainly youths), drug users in 
outpatient drug treatment, and those in the open drug 
scene. Among 12- to 25-year-olds, the lifetime prevalence 
of cocaine use is relatively stable between about 3% in 
1993, 2% in 1997 and 2% in 2001  [10] . Representative 
studies carried out in Hamburg  [11] and Berlin  [12] re-
port higher lifetime-prevalence rates of up to 9.7% among 
18- to 39-year-olds. Cocaine is widely used in recreation-
al settings  [13, 14] . For example, 31–36% of all party-go-
ers from the Munich and Berlin techno scene reported the 
use of cocaine  [15–17] . The importance of the party set-
ting is underlined in a reanalysis of the representative 
study ‘Drug Afﬁ nity among Young People in the Federal 
Republic of Germany’  [10] . Within the group of regular 
party-goers, the 12-month prevalence of cocaine has in-
creased from 2% in 1997 to 4% in 2001, and was four 
times higher than for those who were not regular party-
goers with 1%  [18] . In this setting, cocaine use is mainly 
by means of snorting, yet also through other routes of ad-
ministration  [19] . 
 A second group consists of drug users in outpatient 
drug treatment, mostly opiate users in methadone main-
tenance treatment. According to the results of the Ger-
man treatment documentation system for 2001, 55% of 
the women and 48% of men starting treatment primarily 
because of opiate use are also cocaine users, and 43% of 
both men and women are crack users, too  [20, 21] . 
 The third group of drug users with a high prevalence 
of cocaine is the group of IDUs belonging to the open drug 
scene. In this case, most studies were conducted in Frank-
furt am Main and Hamburg, those German cities with 
large visible drug scenes. In a study of the Hamburg open 
drug scene conducted in 2000, 74% of 616 drug users had 
consumed cocaine or crack within the last 24 h  [25] . Com-
pared to the 63% of cocaine or crack users found 1 year 
earlier in the same population  [22] , this is a further in-
crease, and almost doubled the percentage found 5 years 
earlier  [23] . Furthermore, there is an increase in the use 
of crack cocaine: In 2000 22% had used crack cocaine and 
58% had used cocaine powder within the last 24 h, but in 
2003 71% had used crack cocaine and 29% cocaine pow-
der  [24, 25] . 
 United Kingdom 
 One major ﬁ nding to emerge from the British Crime 
Survey (BCS) has been the concentration of the use of 
cocaine powder among young male adults 16–29 years. 
Five percent of 16- to 29-year-olds reported using cocaine 
in 2000, a 5-fold increase on reports to the 1994 survey 
 [26] . Other non-random studies of speciﬁ c groups, such 
as those attending ‘dance music events’, report consis-
tently high levels of lifetime use of up to 70%, and lifetime 
use of crack cocaine in one sample of 18%  [27, 28] , indi-
cating the increasing popularity of drug use among youth 
cultures. In an early study, Gossop et al.  [29] found crack 
smokers were more likely to be of Afro-Caribbean parent-
age, and more recent studies have reported 18% of the 
sample as Black origin, while approximately half the cli-
ents presenting for treatment were mixed race, Black Brit-
ish, Black Caribbean  [30] . 
 A further sub-population with high rates of crack and 
powder cocaine use exists among individuals within the 
criminal justice system. Finch et al.  [31] reported on the 
prevalence of crack cocaine use in offenders engaged in a 
drug treatment and testing orders. Among a sample of 43, 
19 (54%) had used crack cocaine in the previous 30 days, 
28 (80%) had used crack cocaine in the 6 months prior to 
interview, of whom, 16 had used on more than one day, 
and 32 (61%) met the criteria for crack dependence. Sim-
ilar associations of crack use and crime were found among 
drug users, on admission to treatment and at 4-year fol-
low-up  [32] . Another group with a high prevalence of co-
caine and in particular, crack cocaine use are female sex 
workers, with a lifetime use of 34% and current use of 
10%  [33] . And in a recent study of homeless youth and 
drug use in the UK, lifetime prevalence of cocaine was 
substantially higher at 50%, and 38% for crack cocaine; 
last month prevalence was 15 and 18%, respectively 
 [34] . 
 Shifts in patterns of drug use have also been reported 
among intravenous drug users, with studies recognising 
the increasing rarity of the heroin-only user  [32, 35] . The 
UK National Treatment Outcome Research Study 
(NTORS) found that many opiate users frequently used 
crack cocaine in addition to heroin  [36] . This trend to-
wards combination use was noted as early as 1989 when 
Strang et al.  [37] reported increases in the prevalence of 
cocaine use – in particular crack – among opiate users 
from 13% in 1987 to 29% in 1989. 
 Italy 
 Information is available on cocaine use for two sub-
groups: military recruits and patients in addiction treat-
ment. The ﬁ rst comes from a study carried out in 1996 
amongst military recruits during medical control. The 
data showed that 3% of the 35,000 men (aged 18) used 
cocaine on a daily basis and 5% used cocaine in combina-
tion with other drugs  [38] . For the second subgroup, of 
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the 155,096 patients in public addiction treatment cen-
tres in Italy in the year 2002, around 6% reported using 
cocaine as ﬁ rst drug of choice and 80% reported heroin 
as primary drug, of which 20% report cocaine use as a 
secondary drug  [38] . 
 Ireland 
 The available treatment data indicate an increase in 
the number of individuals presenting at services report-
ing the use of cocaine. The data suggest that cocaine is 
more likely to be a secondary drug than a primary drug 
among treated drug users. There has been a rise of cocaine 
use up to 8% of all contacts. For the year 1998, 72.5% of 
clients presenting with cocaine as either a primary or sec-
ondary drug of misuse were male  [39] . 
 Another subgroup is the homeless: A study of homeless 
drug users carried out in 1999 revealed that all reported 
heroin/methadone as being their primary drug, and 23% 
reported cocaine as being their secondary drug  [40] . A 
study of the Health of Hostel-Dwelling Men in Dublin 
reported lifetime prevalence of 20% for cocaine  [41] . 
Hannon et al.’s  [42]  survey of the prison populations’ 
health, attitudes and nutrition found that 50% of the 
women and 47% of the men reported a lifetime preva-
lence of cocaine, with 24% of the men and 28% of the 
women reporting cocaine use three or more times. 
 Spain 
 As in other countries, there are several reports of high-
er cocaine use prevalence among younger groups. One 
study analysing substance use among military recruits 
found a lifetime prevalence of cocaine use of 12.4%, a 12-
month prevalence of 7.9% and a 30-day prevalence of 
5.4%  [43] . Another study on cocaine use by secondary 
school students found a lifetime prevalence of 6.1%, a 12-
month prevalence of 4.9% and a 30-day prevalence of 
2.7%, yet signiﬁ cantly higher for males than for females 
 [44] . As far as patients in addiction treatment, there has 
been a steady rise in the number of patients treated be-
cause of cocaine dependence and a shift in the primary 
substance of addiction treatment from heroin to cocaine, 
although heroin remains the main problem drug  [45] . 
 Discussion 
 Considering the lack of empirical evidence with re-
spect to cocaine use in Europe, this research project will 
deliver a ﬁ rst broad look at cocaine use in Europe and 
possible consequences for public health strategies. Con-
sidering the association between socio-cultural factors 
and the severity of cocaine use, there is reason to believe 
that the diverse cultural situation in Europe will neces-
sitate speciﬁ c research on both a European, national and 
local level. A multi-centre study can therefore only show 
very general trends that need to be complemented by fur-
ther speciﬁ c research in order to come up with local or 
national strategies. 
 The data on lifetime and 12-month prevalence shows 
an increase for almost all European countries. The gen-
eral increase correlates with efforts by cocaine producers 
and suppliers to capture new markets after the massive 
crackdown in the USA since the late 1980s. Nonetheless, 
the prevalence rates do not reach anywhere near those of 
the USA – the highest rate can be found in the United 
Kingdom with 5.6%, while the overall lifetime prevalence 
in the USA reached almost 18% in 1985. Of some inter-
est is the question, why this general prevalence increase 
in cocaine use has not affected Sweden to the same extent. 
A possible explanation is the fact, that in Sweden amphet-
amines have played a major role compared to other Eu-
ropean countries. Amphetamines are also stimulants, but 
the effects of cocaine and amphetamines are still quite 
different, so that the explanation seems not to be sufﬁ -
cient. Another interesting aspect is the fact that there is 
evidence of a plateau effect in the United Kingdom 
around the year 2000. The plateau experienced in the 
USA around the year 1985 coincided with a strong dis-
cussion in the media on the effects of cocaine use. A sim-
ilar discussion in the media appeared in the late 1990s in 
Europe – should this lead to a plateau in the prevalence 
rates of cocaine use at least in the general population, than 
the cocaine ‘problem’ will not have been anywhere near 
that experienced in the USA. 
 With respect to the special subgroups with signiﬁ cant-
ly higher prevalence rates of cocaine use, the evidence 
from several countries conﬁ rms that cocaine use concen-
trates around three subgroups: (1) youth groups, espe-
cially in a party setting; (2) as a secondary drug among 
opiate addicts, and (3) as a primary drug among margin-
alized sectors of society. Among youth groups the preva-
lence of cocaine use seems to be at least twice as high as 
in the general population. This is of importance for any 
prevention measures, such as those in school settings. 
 For opiate-dependent subjects the increasing rate of 
additional cocaine may reﬂ ect an increased availability 
of methadone maintenance treatment in European coun-
tries, so that not only patients with high compliance are 
included. It remains unclear whether the sedating effects 
of methadone may be responsible for increased use of the 
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stimulant substance cocaine. This may imply the neces-
sity of diversifying maintenance treatment options 
through other opiates (i.e. buprenorphine, slow-release 
morphine, diamorphine). The third group – those in so-
cially marginalized sectors of society – reﬂ ects an increas-
ing problem for European societies that are dismantling 
the traditional welfare state. This group poses the biggest 
challenge for the health care systems with respect to co-
caine (mainly crack) use, as there are not only insufﬁ cient 
treatment options, but also barriers in the access to care, 
that need to be overcome. Therefore, the increasing co-
caine use in Europe may not pose as great a threat to the 
societies as it did in the USA, but certainly will pose a 
great challenge for the reform of the addiction treatment 
system in most European countries. The most critical as-
pect will be the prevalence of crack cocaine use, as its use 
is associated with the greatest difﬁ culties for addiction 
services. 
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